Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots
Thaís Armangué(Universitat de Barcelona), Adeline Vanderver(Children's Hospital of Philadelphia), Camilo Toro(National Human Genome Research Institute), Asako Takanohashi(Children's Hospital of Philadelphia), Davide Tonduti, Mark A. Morrissey(New York State Department of Health), Joseph J. Orsini, Norah Nahhas(Children's National), Alejandro Iglesias(Columbia University Irving Medical Center), Nicole Ulrick(Children's Hospital of Philadelphia), Marjo S. van der Knaap(Amsterdam Neuroscience), Francesco Gavazzi(Children's Hospital of Philadelphia), Keith Van Haren(Stanford University), Guy Helman(Murdoch Children's Research Institute), Heather Gordish‐Dressman(Coriell Institute For Medical Research), Alex Conant(Children's National), Anne B. Moser(Kennedy Krieger Institute), Richard O. Jones(Kennedy Krieger Institute), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Chloe Stutterd(Royal Children's Hospital), Raphaela Goldbach Mansky(Hochschule Niederrhein)
Cited by 52
Related Papers
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
|The Lancet Neurology|2019|853
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
|The Lancet Neurology|2018|645
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617